Submucosal Lifting Agent Market Snapshot (2023 to 2033)

During the projected period, the global submucosal lifting agent market is expected to grow at a CAGR of 6.9%. The market value is projected to increase from US$ 114.2 million in 2023 to US$ 222.6 million by 2033. The global market was valued at US$ 106.9 million at the end of 2022 and is anticipated to exhibit Y-o-Y growth of 6.8% in 2023.

Market Outlook-

Key Market Attributes

Market Size, 2022 US$ 106.9 Million
Market Size, 2023 US$ 114.2 Million
Market Size, 2033 US$ 222.6 Million
Value CAGR (2023 to 2033) 6.9%

The market for submucosal lifting agents includes specific medical goods required for endoscopic procedures. These substances establish a safe separation between the mucosal and muscle layers of the gastrointestinal tract. This allows for more exact vision and less invasive treatment of diseases such as gastrointestinal bleeding, tumors, and polyps.

The rising prevalence of gastrointestinal illnesses, technical developments in endoscopy and increased knowledge about early detection, needs are all driving market expansion. Submucosal lifting agents play an important role in supporting successful and safe treatments, adding to the growth of the market as healthcare infrastructure expands and innovation continues.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Analysis of Historical and Future Outlook for Submucosal Lifting Agent Market

The global submucosal lifting agent market recorded a historic CAGR of 6.4% in the last 5 years from 2017 to 2022. The market value for the submucosal lifting agent market was around 30.8% of the overall US$ 347.0 million of the global endoscopic submucosal dissection market.

Semi Annual Market Update

Particular Value CAGR
H1 6.00% (2022 to 2032)
H2 7.93% (2022 to 2032)
H1 6.30% (2023 to 2033)
H2 7.51% (2023 to 2033)

The increasing demand for minimally invasive surgical procedures and devices is driving the expansion of the submucosal lifting agent market. By providing less traumatic alternatives to standard surgical approaches, minimally invasive techniques have changed the medical world. Smaller incisions, less tissue damage, faster recovery times, and less postoperative pain for patients are all benefits of these operations.

Submucosal injection fluids are critical in improving the efficacy of minimally invasive endoscopic treatments. These agents improve visualization and access for healthcare workers during treatments such as polypectomies, resections, and lesion removal by generating a regulated gap between tissue layers. The use of submucosal lifting agents improves precision and lowers the likelihood of problems.

  • According to the article published in BMC Surgery Journal on July 2020, From January 1st, 2010 to December 31st, 2019, 249 individuals were operated on for gastric cancer, with 141 (56.6%) undergoing open surgery and 108 (43.4%) undergoing laparoscopic surgery.

The submucosal lifting agent market is expected to develop as the demand for minimally invasive procedures rises due to patient preferences for faster recovery and better outcomes. By establishing ideal procedural circumstances, these agents support the goals of minimally invasive operations. Also, advances in the formulations and applications of submucosal lifting agents fit with the ongoing evolution of minimally invasive surgical methods.

In essence, the interaction between minimally invasive surgical devices with submucosal lifting agents creates a positive feedback loop, pushing the expansion of both sectors as they meet the growing demand for improved, patient-friendly medical techniques.

Insight into Growth Drivers influencing Market

The rising prevalence of gastrointestinal problems like upper gastrointestinal bleeding, lower gastrointestinal bleeding, angiodysplasia, esophageal varices and peptic ulcer disease is a key factor driving the submucosal lifting agent market. As the prevalence of disorders such as gastrointestinal bleeding, polyps, and tumors rises, so does the demand for endoscopic operations that require submucosal lifting agents.

  • According to the article published in Stat Pearls Journal on June 2023, UGIB (Upper gastrointestinal bleeding) affects roughly 67/100,000 people, and LGIB (Lower Gastrointestinal Bleeding) affects around 36/100,000 people.

These chemicals form a barrier between tissue layers, allowing for better imaging and treatment. The growing prevalence of gastrointestinal illnesses emphasizes the significance of precise diagnosis and minimally invasive therapies, which supports the use of submucosal lifting agents. The emphasis on early identification and treatment by healthcare professionals amplifies the importance of these agents, positioning the market for growth as they play a crucial role in enhancing procedure results and patient care.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Brief Assessment of Challenges affecting Submucosal Lifting Agent Market

Due to high costs and a scarcity of trained practitioners, the submucosal lifting agent industry faces growth limits. These agent’s development and production costs can raise procedure prices, limiting availability for patients and healthcare facilities.

Likewise, specialized training is essential for practitioners to execute endoscopic procedures with these agents competently, but a dearth of appropriately qualified experts impedes widespread implementation. These constraints hamper market expansion by discouraging potential users from adopting the technology and preventing the incorporation of submucosal lifting agents into ordinary medical practices. Addressing these problems through cost-effective solutions and thorough training programs is critical to realizing this market's full growth potential.

Country wise insights 

Market Growth Outlook by Key Countries

Country Value CAGR
United States 6.8%
Germany 7.9%
United Kingdom 6.3%
Japan 6.0%
China 7.2%
India 10.0%

Key Factors Affecting Submucosal Lifting Agent Market Development

The United States dominates the global market with 38.0% market share in 2022 and is projected to continue experiencing high growth throughout the forecast period. The increased prevalence of gastrointestinal illnesses in the United States, especially colorectal cancer, drives the demand for submucosal lifting agents. These medicines are required for safer and more successful tumor resections and interventions during endoscopic operations.

  • According to the article published in Stat Pearl on June 2023, Every year in the United States, CRC (colorectal cancer) affects around 135,439 estimated new patients, with a corresponding 95,520 (70%) owing to colon cancer. When colon and rectum cancers are combined, it is the second greatest cause of mortality in the United States, accounting for an estimated 50,260 fatalities.

As the incidence of colorectal cancer rises, so does the demand for precise diagnoses and least invasive therapies. Submucosal lifting agents make these surgeries easier and improve patient outcomes. The rising prevalence of gastrointestinal disorders emphasizes the significance of modern medical instruments, positioning the submucosal lifting agent market in the United States for growth.

Brief about Key Countries Leading Submucosal Lifting Agent Market Growth

Germany held about 6.7% share of the global market in 2022 and is projected to increase during the forecast period. Germany presents a leading market for submucosal lifting agents due to the high demand for advanced endoscopic procedures like endoscopic submucosal dissection (ESD). While Germany achieves impressive en bloc resection rates with ESD, curative resection rates remain moderate.

ESD necessitates expertise and varies based on case volume at different centers. The establishment of a multicenter registry highlights the nation's commitment to evaluating and enhancing ESD's technical success, curative rates, long-term outcomes, and economic viability. With limited European ESD data, Germany's focus on quality improvement in this domain makes it a promising market for effective submucosal lifting agents.

Role of Prominent Countries in Submucosal Lifting Agent Market Development

United Kingdom held 6.1% of the global market share in 2022. The submucosal lifting agent market is thriving in the UK due to the rising adoption of endoscopic submucosal dissection (ESD) for gastrointestinal high-grade intramucosal neoplasia and superficially invasive cancer. ESD's en bloc resection offers improved completeness of excision assessment and a lower risk of recurrence for benign lesions.

While piecemeal endoscopic mucosal resection (pEMR) remains favored by some, the benefits of ESD often outweigh drawbacks. The surge in the submucosal lifting agent market is attributed to the growing recognition of ESD's advantages and a shift towards incorporating this advanced technique into local and regional practices.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Insights

Brief About Leading Ingredient in Submucosal Lifting Agent Market

Market Growth Outlook by Key Ingredients

Ingredients Value CAGR
Poloxamer 188 and Polyoxyl-15-hydroxystearate 4.5%
Gellan Gum and Polysaccharide 5.0%
Sodium Hyaluronate 7.5%
Cellulose 6.6%
Absorbable Starch Polymers 7.8%
Poloxamers 9.0%

Sodium hyaluronate within the ingredient segment hold a revenue share of 28.4% in 2022, and the same trend is being followed over the forecasted period. Sodium hyaluronate is extensively used in the submucosal lifting agent market. As a naturally occurring glycosaminoglycan, it plays a pivotal role in wound healing, inflammation, and development. Its viscoelastic properties make it a prime choice in ophthalmic applications, protecting the corneal endothelium and maintaining anterior chamber depth during intraocular surgery.

Recent animal experiments reveal its potential in promoting corneal epithelial wound healing by stimulating cell migration, adhesion, and proliferation. Acting as a ligand for CD44, sodium hyaluronate's involvement in cell interactions and migration during re-epithelialization underscores its significance in the submucosal lifting agent market.

Details on Prominent Application with Dominant Share of the Market

Market Growth Outlook by Key Applications

Applications Value CAGR
Polyps 5.6%
Adenomas 8.4%
Early-stage Cancers 7.4%
Gastrointestinal Mucosal Lesions 8.7%
Others 5.1%

Early-stage cancers held a market share of 32.7% in 2022. In the Submucosal Lifting Agent Market, a dominant application is the management of early-stage cancers within the gastrointestinal tract. Submucosal injection of lifting agent’s aids in endoscopic mucosal resection (EMR) and endoscopic submucosal dissection (ESD), techniques used for excising neoplasms confined to the mucosa or submucosa. This technique cushions polyps, adenomas, and early-stage cancers, enabling effective excision.

Synthetic agents like Eleview® and ORISE® have gained popularity due to extended submucosal fluid maintenance, reducing procedure times. ORISE® notably triggers a foreign body-type giant cell reaction, known as 'lifting agent granuloma.' These advancements underscore submucosal lifting agents' role in minimally invasive, effective early-stage cancer removal within the gastrointestinal tract.

Overview of End User Shaping the Global Market

Market Growth Outlook by Key End Users

End Users Value CAGR
Hospitals 6.7%
Specialty Clinics 6.2%
Surgical Centers 7.9%
Others 7.4%

Hospitals held a market share of 37.0% in 2022. Given their role as key locations for surgical procedures, hospitals dominate the end-user segment of the submucosal lifting agent market. The regulated environment, the availability of experienced medical professionals, and the necessity for sophisticated surgical equipment drive the need for submucosal lifting agents. The fact that hospitals have a large caseload and a focus on patient outcomes solidifies their position as the major users of these novel surgical instruments.

Competitive Landscape

Leading submucosal lifting agent manufacturers prioritize strategic collaborations as they attempt to develop new product lines and increase their global consumer base.

  • In October 2021, Laborie Medical Technologies acquires Pelvalon, a female fecal incontinence device, for its fourth acquisition in four years. The Eclipse system, designed for 18-75 women, will be scaled up for more physicians and patients.

Similarly, recent developments related to companies in the submucosal lifting agent market have been tracked by the team at Future Market Insights, which are available in the full report.

Related Market Growth Outlook Scenario

Particulars Value CAGR
Gastroesophageal Reflux Disease (GERD) Devices Market 4.0%
Gastroesophageal Junction Adenocarcinoma Therapeutics Market 18.0%
Gastrointestinal Stromal Tumor (GIST) Therapeutics Market 6.0%

Report Scope as per Submucosal Lifting Agent Industry Analysis

Attribute Details
Forecast Period 2023 to 2033
Historical Data Available for 2017 to 2022
Market Analysis USD Million for Value
Key Regions Covered North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East and Africa
Key Countries Covered United States, Canada, Brazil, Mexico, Argentina, United Kingdom, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa, and Northern Africa
Key Market Segments Covered Ingredient, Application, End User and Region
Key Companies Profiled Laborie; STERIS; Olympus America; Medtronic; Boston Scientific Corporation; Omnimed Ltd™; COSMO PHARMACEUTICALS; Micro-Tech Endoscopy; Ovesco Endoscopy AG
Report Coverage Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives
Pricing Available upon Request

Key Market Segments Covered in Submucosal Lifting Agent Industry Research

By Ingredient:

  • Poloxamer 188 and Polyoxyl-15-hydroxystearate
  • Gellan gum and Polysaccharide
  • Sodium Hyaluronate
  • Cellulose
  • Absorbable Starch Polymers
  • Poloxamers

By Application:

  • Polyps
  • Adenomas
  • Early-stage Cancers
  • Gastrointestinal Mucosal Lesions
  • Others

By End User:

  • Hospitals
  • Specialty Clinics
  • Surgical Centers
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

How large is the global market in 2022?

The global market is currently valued at around US$ 106.9 million in 2022.

What is the global market estimated to reach by 2023?

The global estimate for 2023 is around US$ 114.2 million.

What is the global market projected value for 2033?

The global market is set to reach a valuation of around US$ 222.6 million by 2033.

What is the sales forecast for the global market through 2033?

Sales of the market are set to witness growth at a CAGR of 6.9% between 2023 and 2033.

What was the last 5 years CAGR for the global market?

Demand for the global market increased at a 6.4% CAGR from 2017 to 2022.

Which countries/regions drive the demand within the submucosal lifting agent?

The United States, Germany, United Kingdom, Japan and Australia account for most demand within the market, currently holding around 59.5% market share.

What is the United States market outlook?

The United States accounts for around 38.0% share of the global market in 2022.

What is the Germany market outlook?

The Germany market held a share of about 20.4% in the European market in 2022.

What is the United Kingdom market outlook?

United Kingdom accounts for around 6.1% share of the global market in 2022.

Which application contributes more to the submucosal lifting agent market?

Early-stage cancers segment held 32.7% share of the global market in 2022.

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand Side Trends
    1.3. Supply-Side Trends
    1.4. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
    2.3. Inclusions and Exclusions
3. Key Market Trends
    3.1. Key Trends Impacting the Market
    3.2. Product Innovation / Development Trends
4. Value Added Insights
    4.1. Product Adoption/Usage Analysis
    4.2. Products USP/ Features Analysis
    4.3. Regulatory Approvals and Guidelines
    4.4. Growing Gastrointestinal Disorders
    4.5. Clinical Applications of Imaging Techniques in Diagnosis
    4.6. Regulatory Landscape
        4.6.1. Regulatory Frameworks in United States
        4.6.2. Regulatory Frameworks in Europe
        4.6.3. Regulatory Frameworks in India
        4.6.4. Regulatory Frameworks in Australia
    4.7. Porter’s Analysis
    4.8. PESTLE Analysis
    4.9. Value Chain Analysis
    4.10. Unmet Needs
5. Market Background
    5.1. Macro-Economic Factors
        5.1.1. Global Healthcare Expenditure
        5.1.2. Global Life Expectancy Market Outlook
        5.1.3. Research and Development funding by Region
        5.1.4. Global Diagnostic Ultrasound Market Overview – Parent Market Analysis
    5.2. Forecast Factors - Relevance and Impact
        5.2.1. Increasing Endoscopic Procedures
        5.2.2. Rising Gastrointestinal Disorders
        5.2.3. Advancements in Endoscopic Techniques
        5.2.4. Growing Aging Population
        5.2.5. Rise in Outpatient Procedures
        5.2.6. Prevalence of Obesity-related Disorders
        5.2.7. Increasing Healthcare Expenditure
        5.2.8. Advancements in Material Science
    5.3. Market Dynamics
        5.3.1. Drivers
        5.3.2. Restraints
        5.3.3. Opportunity Analysis
6. Global Market Demand (in Volume) Analysis 2017 to 2022 and Forecast, 2023 to 2033
    6.1. Historical Market Volume (Units) Analysis, 2017 to 2022
    6.2. Current and Future Market Volume (Units) Analysis and Forecast Projections, 2023 to 2033
        6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market – Pricing Assessment
    7.1. Regional Pricing Analysis
    7.2. Pricing Break-up
    7.3. Global Average Pricing Analysis Benchmark
    7.4. Pricing Assumptions
8. Global Market Demand (in Value or Size in US$ Million) Analysis 2017 to 2022 and Forecast, 2023 to 2033
    8.1. Historical Market Value (US$ Million) Analysis, 2017 to 2022
    8.2. Current and Future Market Size (US$ Million) Analysis and Forecast Projections, 2023 to 2033
        8.2.1. Y-o-Y Growth Trend Analysis
        8.2.2. Absolute $ Opportunity Analysis
    8.3. Revenue Opportunity Scenario- Likely/Conservative/Optimistic
9. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Ingredient
    9.1. Introduction / Key Findings
    9.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Ingredient, 2017 to 2022
    9.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Ingredient, 2023 to 2033
        9.3.1. Poloxamer 188 and Polyoxyl-15-hydroxystearate
        9.3.2. Gellan gum and Polysaccharide
        9.3.3. Sodium hyaluronate
        9.3.4. Cellulose
        9.3.5. Absorbable starch polymers
        9.3.6. Poloxamers
    9.4. Market Attractiveness Analysis By Ingredient
10. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
    10.1. Introduction / Key Findings
    10.2. Historical Market Size (US$ Million) Analysis By Application, 2017 to 2022
    10.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
        10.3.1. Polyps
        10.3.2. Adenomas
        10.3.3. Early-stage cancers
        10.3.4. Gastrointestinal mucosal lesions
        10.3.5. Others
    10.4. Market Attractiveness Analysis By Application
11. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User
    11.1. Introduction / Key Findings
    11.2. Historical Market Size (US$ Million) Analysis By End User, 2017 to 2022
    11.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End User, 2023 to 2033
        11.3.1. Hospitals
        11.3.2. Specialty Clinics
        11.3.3. Surgical Centers
        11.3.4. Others
    11.4. Market Attractiveness Analysis By End User
12. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, by Region
    12.1. Introduction / Key Findings
    12.2. Historical Market Size (US$ Million) and Volume (Units) Analysis By Region, 2017 to 2022
    12.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Region, 2023 to 2033
        12.3.1. North America
        12.3.2. Latin America
        12.3.3. Europe
        12.3.4. South Asia
        12.3.5. East Asia
        12.3.6. Oceania
        12.3.7. Middle East and Africa
    12.4. Market Attractiveness Analysis By Region
13. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    13.1. Introduction / Key Findings
    13.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
    13.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        13.3.1. By Country
            13.3.1.1. United States
            13.3.1.2. Canada
        13.3.2. By Ingredient
        13.3.3. By Application
        13.3.4. By End User
    13.4. Market Attractiveness Analysis By Region
        13.4.1. By Country
        13.4.2. By Ingredient
        13.4.3. By Application
        13.4.4. By End User
    13.5. Market trends
    13.6. Key Market Participants - Intensity Mapping
    13.7. Drivers and Restraints - Impact Analysis
    13.8. Country Level Analysis and Forecast
        13.8.1. United States Market Analysis
            13.8.1.1. Introduction
            13.8.1.2. Market Analysis and Forecast by Market Taxonomy
                13.8.1.2.1. By Ingredient
                13.8.1.2.2. By Application
                13.8.1.2.3. By End User
        13.8.2. Canada Market Analysis
            13.8.2.1. Introduction
            13.8.2.2. Market Analysis and Forecast by Market Taxonomy
                13.8.2.2.1. By Ingredient
                13.8.2.2.2. By Application
                13.8.2.2.3. By End User
14. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    14.1. Introduction / Key Findings
    14.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
    14.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        14.3.1. By Country
            14.3.1.1. Brazil
            14.3.1.2. Mexico
            14.3.1.3. Argentina
            14.3.1.4. Rest of Latin America
        14.3.2. By Ingredient
        14.3.3. By Application
        14.3.4. By End User
    14.4. Market Attractiveness Analysis By Region
        14.4.1. By Country
        14.4.2. By Ingredient
        14.4.3. By Application
        14.4.4. By End User
    14.5. Market trends
    14.6. Key Market Participants - Intensity Mapping
    14.7. Drivers and Restraints - Impact Analysis
    14.8. Country Level Analysis and Forecast
        14.8.1. Brazil Market Analysis
            14.8.1.1. Introduction
            14.8.1.2. Market Analysis and Forecast by Market Taxonomy
                14.8.1.2.1. By Ingredient
                14.8.1.2.2. By Application
                14.8.1.2.3. By End User
        14.8.2. Mexico Market Analysis
            14.8.2.1. Introduction
            14.8.2.2. Market Analysis and Forecast by Market Taxonomy
                14.8.2.2.1. By Ingredient
                14.8.2.2.2. By Application
                14.8.2.2.3. By End User
        14.8.3. Argentina Market Analysis
            14.8.3.1. Introduction
            14.8.3.2. Market Analysis and Forecast by Market Taxonomy
                14.8.3.2.1. By Ingredient
                14.8.3.2.2. By Application
                14.8.3.2.3. By End User
15. Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    15.1. Introduction / Key Findings
    15.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
    15.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        15.3.1. By Country
            15.3.1.1. United Kingdom
            15.3.1.2. Germany
            15.3.1.3. Italy
            15.3.1.4. France
            15.3.1.5. Spain
            15.3.1.6. Russia
            15.3.1.7. BENELUX
            15.3.1.8. Rest of Europe
        15.3.2. By Ingredient
        15.3.3. By Application
        15.3.4. By End User
    15.4. Market Attractiveness Analysis By Region
        15.4.1. By Country
        15.4.2. By Ingredient
        15.4.3. By Application
        15.4.4. By End User
    15.5. Market trends
    15.6. Key Market Participants - Intensity Mapping
    15.7. Drivers and Restraints - Impact Analysis
    15.8. Country Level Analysis and Forecast
        15.8.1. United Kingdom Market Analysis
            15.8.1.1. Introduction
            15.8.1.2. Market Analysis and Forecast by Market Taxonomy
                15.8.1.2.1. By Ingredient
                15.8.1.2.2. By Application
                15.8.1.2.3. By End User
        15.8.2. Germany Market Analysis
            15.8.2.1. Introduction
            15.8.2.2. Market Analysis and Forecast by Market Taxonomy
                15.8.2.2.1. By Ingredient
                15.8.2.2.2. By Application
                15.8.2.2.3. By End User
        15.8.3. Italy Market Analysis
            15.8.3.1. Introduction
            15.8.3.2. Market Analysis and Forecast by Market Taxonomy
                15.8.3.2.1. By Ingredient
                15.8.3.2.2. By Application
                15.8.3.2.3. By End User
        15.8.4. France Market Analysis
            15.8.4.1. Introduction
            15.8.4.2. Market Analysis and Forecast by Market Taxonomy
                15.8.4.2.1. By Ingredient
                15.8.4.2.2. By Application
                15.8.4.2.3. By End User
        15.8.5. Spain Market Analysis
            15.8.5.1. Introduction
            15.8.5.2. Market Analysis and Forecast by Market Taxonomy
                15.8.5.2.1. By Ingredient
                15.8.5.2.2. By Application
                15.8.5.2.3. By End User
        15.8.6. Russia Market Analysis
            15.8.6.1. Introduction
            15.8.6.2. Market Analysis and Forecast by Market Taxonomy
                15.8.6.2.1. By Ingredient
                15.8.6.2.2. By Application
                15.8.6.2.3. By End User
        15.8.7. BENELUX Market Analysis
            15.8.7.1. Introduction
            15.8.7.2. Market Analysis and Forecast by Market Taxonomy
                15.8.7.2.1. By Ingredient
                15.8.7.2.2. By Application
                15.8.7.2.3. By End User
16. South Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    16.1. Introduction / Key Findings
    16.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
    16.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        16.3.1. By Country
            16.3.1.1. India
            16.3.1.2. Indonesia
            16.3.1.3. Thailand
            16.3.1.4. Malaysia
            16.3.1.5. Rest of South Asia
        16.3.2. By Ingredient
        16.3.3. By Application
        16.3.4. By End User
    16.4. Market Attractiveness Analysis By Region
        16.4.1. By Country
        16.4.2. By Ingredient
        16.4.3. By Application
        16.4.4. By End User
    16.5. Market trends
    16.6. Key Market Participants - Intensity Mapping
    16.7. Drivers and Restraints - Impact Analysis
    16.8. Country Level Analysis and Forecast
        16.8.1. India Market Analysis
            16.8.1.1. Introduction
            16.8.1.2. Market Analysis and Forecast by Market Taxonomy
                16.8.1.2.1. By Ingredient
                16.8.1.2.2. By Application
                16.8.1.2.3. By End User
        16.8.2. Indonesia Market Analysis
            16.8.2.1. Introduction
            16.8.2.2. Market Analysis and Forecast by Market Taxonomy
                16.8.2.2.1. By Ingredient
                16.8.2.2.2. By Application
                16.8.2.2.3. By End User
        16.8.3. Thailand Market Analysis
            16.8.3.1. Introduction
            16.8.3.2. Market Analysis and Forecast by Market Taxonomy
                16.8.3.2.1. By Ingredient
                16.8.3.2.2. By Application
                16.8.3.2.3. By End User
        16.8.4. Malaysia Market Analysis
            16.8.4.1. Introduction
            16.8.4.2. Market Analysis and Forecast by Market Taxonomy
                16.8.4.2.1. By Ingredient
                16.8.4.2.2. By Application
                16.8.4.2.3. By End User
17. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    17.1. Introduction / Key Findings
    17.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
    17.3. Current and Future Market Size (US$ Million) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        17.3.1. By Country
            17.3.1.1. China
            17.3.1.2. Japan
            17.3.1.3. South Korea
        17.3.2. By Ingredient
        17.3.3. By Application
        17.3.4. By End User
    17.4. Market Attractiveness Analysis By Region
        17.4.1. By Country
        17.4.2. By Ingredient
        17.4.3. By Application
        17.4.4. By End User
    17.5. Market trends
    17.6. Key Market Participants - Intensity Mapping
    17.7. Drivers and Restraints - Impact Analysis
    17.8. Country Level Analysis and Forecast
        17.8.1. China Market Analysis
            17.8.1.1. Introduction
            17.8.1.2. Market Analysis and Forecast by Market Taxonomy
                17.8.1.2.1. By Ingredient
                17.8.1.2.2. By Application
                17.8.1.2.3. By End User
        17.8.2. Japan Market Analysis
            17.8.2.1. Introduction
            17.8.2.2. Market Analysis and Forecast by Market Taxonomy
                17.8.2.2.1. By Ingredient
                17.8.2.2.2. By Application
                17.8.2.2.3. By End User
        17.8.3. South Korea Market Analysis
            17.8.3.1. Introduction
            17.8.3.2. Market Analysis and Forecast by Market Taxonomy
                17.8.3.2.1. By Ingredient
                17.8.3.2.2. By Application
                17.8.3.2.3. By End User
18. Oceania Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    18.1. Introduction / Key Findings
    18.2. Historical Market Size (US$ Million) and Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
    18.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        18.3.1. By Country
            18.3.1.1. Australia
            18.3.1.2. New Zealand
        18.3.2. By Ingredient
        18.3.3. By Application
        18.3.4. By End User
    18.4. Market Attractiveness Analysis By Region
        18.4.1. By Country
        18.4.2. By Ingredient
        18.4.3. By Application
        18.4.4. By End User
    18.5. Market trends
    18.6. Key Market Participants - Intensity Mapping
    18.7. Drivers and Restraints - Impact Analysis
    18.8. Country Level Analysis and Forecast
        18.8.1. Australia Market Analysis
            18.8.1.1. Introduction
            18.8.1.2. Market Analysis and Forecast by Market Taxonomy
                18.8.1.2.1. By Ingredient
                18.8.1.2.2. By Application
                18.8.1.2.3. By End User
        18.8.2. New Zealand Market Analysis
            18.8.2.1. Introduction
            18.8.2.2. Market Analysis and Forecast by Market Taxonomy
                18.8.2.2.1. By Ingredient
                18.8.2.2.2. By Application
                18.8.2.2.3. By End User
19. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033
    19.1. Introduction / Key Findings
    19.2. Historical Market Size (US$ Million) Volume (Units) Analysis, By Market Taxonomy, 2017 to 2022
    19.3. Current and Future Market Size (US$ Million) Volume (Units) Analysis and Forecast By Market Taxonomy, 2023 to 2033
        19.3.1. By Country
            19.3.1.1. GCC Countries
            19.3.1.2. Türkiye
            19.3.1.3. South Africa
            19.3.1.4. Northern Africa
            19.3.1.5. Rest of Middle East and Africa
        19.3.2. By Ingredient
        19.3.3. By Application
        19.3.4. By End User
    19.4. Market Attractiveness Analysis By Region
        19.4.1. By Country
        19.4.2. By Ingredient
        19.4.3. By Application
        19.4.4. By End User
    19.5. Market trends
    19.6. Key Market Participants - Intensity Mapping
    19.7. Drivers and Restraints - Impact Analysis
    19.8. Country Level Analysis and Forecast
        19.8.1. GCC Countries Market Analysis
            19.8.1.1. Introduction
            19.8.1.2. Market Analysis and Forecast by Market Taxonomy
                19.8.1.2.1. By Ingredient
                19.8.1.2.2. By Application
                19.8.1.2.3. By End User
        19.8.2. Türkiye Market Analysis
            19.8.2.1. Introduction
            19.8.2.2. Market Analysis and Forecast by Market Taxonomy
                19.8.2.2.1. By Ingredient
                19.8.2.2.2. By Application
                19.8.2.2.3. By End User
        19.8.3. South Africa Market Analysis
            19.8.3.1. Introduction
            19.8.3.2. Market Analysis and Forecast by Market Taxonomy
                19.8.3.2.1. By Ingredient
                19.8.3.2.2. By Application
                19.8.3.2.3. By End User
        19.8.4. Northern Africa Market Analysis
            19.8.4.1. Introduction
            19.8.4.2. Market Analysis and Forecast by Market Taxonomy
                19.8.4.2.1. By Ingredient
                19.8.4.2.2. By Application
                19.8.4.2.3. By End User
20. Market Structure Analysis
    20.1. Market Analysis by Tier of Companies
    20.2. Market Share Analysis of Top Players (%)
    20.3. Market Concentration
21. Competition Analysis
    21.1. Competition Dashboard
    21.2. Competition Deep Dive
        21.2.1. Laborie
            21.2.1.1. Overview
            21.2.1.2. Product Portfolio
            21.2.1.3. Key Financials
            21.2.1.4. Sales Footprint
            21.2.1.5. SWOT Analysis
            21.2.1.6. Strategy Overview
                21.2.1.6.1. Marketing Strategies
                21.2.1.6.2. Product Strategies
                21.2.1.6.3. Channel Strategies
        21.2.2. STERIS
            21.2.2.1. Overview
            21.2.2.2. Product Portfolio
            21.2.2.3. Key Financials
            21.2.2.4. Sales Footprint
            21.2.2.5. SWOT Analysis
            21.2.2.6. Strategy Overview
                21.2.2.6.1. Marketing Strategies
                21.2.2.6.2. Product Strategies
                21.2.2.6.3. Channel Strategies
        21.2.3. Olympus America
            21.2.3.1. Overview
            21.2.3.2. Product Portfolio
            21.2.3.3. Key Financials
            21.2.3.4. Sales Footprint
            21.2.3.5. SWOT Analysis
            21.2.3.6. Strategy Overview
                21.2.3.6.1. Marketing Strategies
                21.2.3.6.2. Product Strategies
                21.2.3.6.3. Channel Strategies
        21.2.4. Medtronic
            21.2.4.1. Overview
            21.2.4.2. Product Portfolio
            21.2.4.3. Key Financials
            21.2.4.4. Sales Footprint
            21.2.4.5. SWOT Analysis
            21.2.4.6. Strategy Overview
                21.2.4.6.1. Marketing Strategies
                21.2.4.6.2. Product Strategies
                21.2.4.6.3. Channel Strategies
        21.2.5. Boston Scientific Corporation
            21.2.5.1. Overview
            21.2.5.2. Product Portfolio
            21.2.5.3. Key Financials
            21.2.5.4. Sales Footprint
            21.2.5.5. SWOT Analysis
            21.2.5.6. Strategy Overview
                21.2.5.6.1. Marketing Strategies
                21.2.5.6.2. Product Strategies
                21.2.5.6.3. Channel Strategies
        21.2.6. Omnimed Ltd™
            21.2.6.1. Overview
            21.2.6.2. Product Portfolio
            21.2.6.3. Key Financials
            21.2.6.4. Sales Footprint
            21.2.6.5. SWOT Analysis
            21.2.6.6. Strategy Overview
                21.2.6.6.1. Marketing Strategies
                21.2.6.6.2. Product Strategies
                21.2.6.6.3. Channel Strategies
        21.2.7. COSMO PHARMACEUTICALS
            21.2.7.1. Overview
            21.2.7.2. Product Portfolio
            21.2.7.3. Key Financials
            21.2.7.4. Sales Footprint
            21.2.7.5. SWOT Analysis
            21.2.7.6. Strategy Overview
                21.2.7.6.1. Marketing Strategies
                21.2.7.6.2. Product Strategies
                21.2.7.6.3. Channel Strategies
        21.2.8. Micro-Tech Endoscopy
            21.2.8.1. Overview
            21.2.8.2. Product Portfolio
            21.2.8.3. Key Financials
            21.2.8.4. Sales Footprint
            21.2.8.5. SWOT Analysis
            21.2.8.6. Strategy Overview
                21.2.8.6.1. Marketing Strategies
                21.2.8.6.2. Product Strategies
                21.2.8.6.3. Channel Strategies
        21.2.9. Ovesco Endoscopy AG
            21.2.9.1. Overview
            21.2.9.2. Product Portfolio
            21.2.9.3. Key Financials
            21.2.9.4. Sales Footprint
            21.2.9.5. SWOT Analysis
            21.2.9.6. Strategy Overview
                21.2.9.6.1. Marketing Strategies
                21.2.9.6.2. Product Strategies
                21.2.9.6.3. Channel Strategies
22. Assumptions and Acronyms Used
23. Research Methodology
Recommendations

Healthcare

Gastroesophageal Reflux Disease (GERD) Device Market

March 2024

REP-GB-1741

315 pages

Healthcare

Gastrointestinal Stromal Tumor (GIST) Therapeutics Market

February 2023

REP-GB-16670

288 pages

Healthcare

Gastroesophageal Reflux Disease Therapeutics Market

November 2022

REP-GB-1410

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Submucosal Lifting Agent Market

Schedule a Call